Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...
SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...
They found something surprising. Women taking beta-blockers had almost a 5% higher chance of developing heart failure than men if they were hospitalized for a heart problem called acute coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback